Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,14 USD | +1,27% | -6,67% | -28,21% |
15/04 | CytoDyn Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 29 februari 2024 | CI |
05/03 | Transcript : CytoDyn Inc. - Special Call |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 65 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03-05-23 |
Joseph Meidling
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Melissa Palmer
CTO | Chief Tech/Sci/R&D Officer | - | 24-05-23 |
Cyrus Arman
COO | Chief Operating Officer | 43 | 09-07-22 |
Chief Tech/Sci/R&D Officer | 59 | 01-08-20 | |
Cristina de Leon
IRC | Investor Relations Contact | - | - |
Tyler Blok
LAW | General Counsel | 37 | 25-07-22 |
Seenu Srinivasan
LAW | General Counsel | - | 07-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13-10-22 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24-08-22 |
Karen Brunke
BRD | Director/Board Member | 72 | 01-04-22 |
Lishomwa Ndhlovu
BRD | Director/Board Member | 54 | 24-11-21 |
Tanya Urbach
CHM | Chairman | 57 | 24-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 9 000 | 0 | 0 | 99,15 % |
Aandeel B | 0 | 6 000 | 0 | 0 | |
Aandeel C | 0 | 19 000 | 0 | 0 | |
Aandeel D | 1 | 993 809 000 | 985 393 715 ( 99,15 %) | 443 000 ( 0,0446 %) |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-28,21% | 137 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |
- Beurs
- Aandelen
- Koers CYDY
- Onderneming CytoDyn Inc.